| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure
|
Thepot, Sylvain
|
|
2014
|
38 |
12 |
p. 1430-1434
5 p.
|
artikel
|
| 2 |
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a retrospective analysis
|
Merchionne, Francesca
|
|
2014
|
38 |
12 |
p. 1446-1450
5 p.
|
artikel
|
| 3 |
Derivation and validation of the SEER-Medicare myelodysplastic syndromes risk score (SMMRS)
|
Uno, Hajime
|
|
2014
|
38 |
12 |
p. 1420-1424
5 p.
|
artikel
|
| 4 |
Editorial board and publication information
|
|
|
2014
|
38 |
12 |
p. IFC-
1 p.
|
artikel
|
| 5 |
First line and salvage therapy with total therapy 3-based treatment for multiple myeloma––An extended single center experience
|
Muchtar, Eli
|
|
2014
|
38 |
12 |
p. 1401-1406
6 p.
|
artikel
|
| 6 |
Functional analysis of the SEPT9-ABL1 chimeric fusion gene derived from T-prolymphocytic leukemia
|
Kawai, Hidetsugu
|
|
2014
|
38 |
12 |
p. 1451-1459
9 p.
|
artikel
|
| 7 |
How tyrosine kinase inhibitors impair metabolism and endocrine system function: A systematic updated review
|
Breccia, Massimo
|
|
2014
|
38 |
12 |
p. 1392-1398
7 p.
|
artikel
|
| 8 |
Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendations
|
Santini, Valeria
|
|
2014
|
38 |
12 |
p. 1381-1391
11 p.
|
artikel
|
| 9 |
Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: A comprehensive large-scale study from a single Chinese center
|
Qin, Ya-Zhen
|
|
2014
|
38 |
12 |
p. 1435-1440
6 p.
|
artikel
|
| 10 |
Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia
|
Kempf, Emmanuelle
|
|
2014
|
38 |
12 |
p. 1425-1429
5 p.
|
artikel
|
| 11 |
Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias
|
Schuler, E.
|
|
2014
|
38 |
12 |
p. 1413-1419
7 p.
|
artikel
|
| 12 |
Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia
|
Liedtke, Michaela
|
|
2014
|
38 |
12 |
p. 1441-1445
5 p.
|
artikel
|
| 13 |
Socioeconomic status and event free survival in pediatric acute lymphoblastic leukemia: A population-based cohort study
|
Gupta, Sumit
|
|
2014
|
38 |
12 |
p. 1407-1412
6 p.
|
artikel
|
| 14 |
Stromal cells attenuate the cytotoxicity of imatinib on Philadelphia chromosome-positive leukemia cells by up-regulating the VE-cadherin/β-catenin signal
|
Chen, Chong
|
|
2014
|
38 |
12 |
p. 1460-1468
9 p.
|
artikel
|
| 15 |
Thinking outside of ABL1 for resistance to tyrosine kinase inhibitors: A perspective of the SEPT9-ABL1 fusion protein
|
Hu, Tinghui
|
|
2014
|
38 |
12 |
p. 1399-1400
2 p.
|
artikel
|
Tijdschrift beschrijving